文献速递神经核医学

早期相18F-Florbetaben PET可作为18F-FDG PET的替代方法

Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET.
PubMed 文献 · Clin Nucl Med · 2020-01-01

该前瞻性研究纳入35例临床怀疑认知下降或痴呆的患者和5名健康对照,比较早期相18F-Florbetaben PET(E-FBB)与18F-FDG PET的关系。结果显示,E-FBB与FDG PET在区域性SUVR和视觉评分上均显著相关(P<0.0001),且两者判定的疾病类型显著相关,但FDG PET的SUVR值和视觉评分显示的摄取减低更严重。结论认为E-FBB PET可能作为FDG PET的替代生物标志物用于痴呆诊断,但疾病严重程度仍以FDG PET判断更准确。

要点

  • E-FBB PET与FDG PET的区域SUVR在所有脑区均显著相关(P<0.0001)。
  • E-FBB与FDG PET视觉评分显著相关(P<0.0001),但FDG PET显示摄取减低更严重。
  • E-FBB可替代FDG PET用于痴呆诊断,但严重程度评估仍以FDG PET更准确。

核心结论

  • E-FBB PET可能作为FDG PET的替代生物标志物用于痴呆诊断。
  • 疾病严重程度仍以FDG PET判断更准确。

研究设计与样本

  • 前瞻性研究纳入35例临床怀疑认知下降或痴呆的患者和5名健康对照,共40名受试者。
  • 所有受试者均采集脑MRI、E-FBB PET、晚期FBB PET和FDG PET。
  • 采用基于个体MRI的皮层表面感兴趣区分析计算区域性SUVR,并分析E-FBB与FDG PET的关系。
  • 所有PET扫描按视觉评分系统评分和分析,并分析摄取模式以判定疾病。

主要发现

  • 40名受试者中,晚期FBB PET显示19例淀粉样蛋白阳性、21例淀粉样蛋白阴性。
  • E-FBB与FDG PET的区域性SUVR在所有脑区均显著相关(P<0.0001)。
  • FDG PET的SUVR值在统计学上高于E-FBB PET。
  • E-FBB与FDG PET的视觉评分显著相关(P<0.0001),但FDG PET的示踪剂摄取减低被认为更严重。
  • E-FBB与FDG PET判定的疾病类型在统计学上相关。

临床怎么用

  • 在需要脑代谢显像但FDG不可及时,可考虑以E-FBB PET替代FDG PET用于痴呆诊断。
  • 判断疾病严重程度时仍应优先依据FDG PET。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Based on the possibility that early-phase florbetaben (E-FBB) brain PET can be a surrogate for brain perfusion imaging, we conducted this study to investigate the clinical utility of E-FBB PET instead of F-FDG brain PET. MATERIALS AND METHODS: This prospective study included 35 patients with clinical suspicion of cognitive decline or dementia and 5 healthy controls. Brain MRI, E-FBB PET, late-phase FBB PET, and FDG PET were acquired. The regional SUV ratios (SUVRs) were calculated by cortical surface region of interest analysis using individual MRI, and relationship between E-FBB and FDG PET was analyzed. All PET scans were scored and analyzed as per visual scoring system, which represent tracer uptake abnormality. Moreover, uptake patterns were analyzed to determine the disease. RESULTS: Among the 40 subjects, 19 were amyloid-positive and 21 were amyloid-negative on late-phase FBB PET. Cortical surface region of interest analysis conducted for comparing between E-FBB and FDG PET revealed significant correlations (P < 0.0001) for regional SUVR among all brain regions; however, the SUVR values of FDG PET were statistically higher than those of E-FBB PET. Similarly, although the visually rated scores for E-FBB and FDG PET showed significant correlation (P < 0.0001), it was considered that the tracer uptake was more severely decreased for FDG PET. The disease types, specified by E-FBB and FDG PET, were statistically correlated. CONCLUSIONS: E-FBB PET could potentially be a useful biomarker for the diagnosis of dementia in place of FDG PET. Nevertheless, the severity of the disease was more accurately determined by FDG PET.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Son SH, Kang K, Ko PW, et al. Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET. Clin Nucl Med. 2020. PMID: 31524679. doi:10.1097/RLU.0000000000002768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。